These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4160610)

  • 41. Studies of ACTH antibodies and their reactions with inactive analogues of ACTH.
    Fleischer N; Givens JR; Abe K; Nicholson WE; Liddle GW
    Endocrinology; 1966 May; 78(5):1067-75. PubMed ID: 4160679
    [No Abstract]   [Full Text] [Related]  

  • 42. Biologic activity and morphology of three types of rabbit IgM antibody subunits.
    Chesebro B; Svehag SE
    J Immunol; 1969 Apr; 102(4):1064-73. PubMed ID: 4181246
    [No Abstract]   [Full Text] [Related]  

  • 43. USE OF MICRO TECHNIQUE FOR SERUM NEUTRALIZATION AND VIRUS IDENTIFICATION.
    LAMB GA; PLEXICO K; GLEZEN WP; CHIN TD
    Public Health Rep (1896); 1965 May; 80(5):463-6. PubMed ID: 14290598
    [No Abstract]   [Full Text] [Related]  

  • 44. Neutralization of poliovirus by polyclonal antibodies requires binding of a single IgG molecule per virion.
    Wetz K; Willingmann P; Zeichhardt H; Habermehl KO
    Arch Virol; 1986; 91(3-4):207-20. PubMed ID: 3022677
    [TBL] [Abstract][Full Text] [Related]  

  • 45. STANDARDIZATION OF POLIOMYELITIS IMMUNE GLOBULIN.
    UHLENDORF BW; BROWN ER; FABISCH PH; HOTTLE GA
    J Immunol; 1964 May; 92():806-10. PubMed ID: 14170423
    [No Abstract]   [Full Text] [Related]  

  • 46. Reactivity of neutralizing antibodies with different specificities to H particles of poliovirus.
    Urasawa T; Urasawa S; Taniguchi K
    Microbiol Immunol; 1979; 23(7):651-7. PubMed ID: 228166
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [FATE OF ANTIBODIES DURING THE COURSE OF SPONTANEOUS CLEAVAGE OF PLACENTAL GAMMA GLOBULIN AND THE INHIBITORY EFFECT OF EPSILON-AMINOCAPROIC ACID (EACA)].
    SKVARIL F; GRUENBERGER D; DREVO M; SLONIM D; STRAUSS J
    Cesk Epidemiol Mikrobiol Imunol; 1964 Nov; 13():343-50. PubMed ID: 14245903
    [No Abstract]   [Full Text] [Related]  

  • 48. [ON POLIOVIRUS NEUTRALIZING ANTIBODIES IN HUMAN MILK. 1. RESULTS IN DETERMINING POLIO NEUTRALIZING ANTIBODIES IN HUMAN MILK].
    TABASHI K
    Nihon Shonika Gakkai Zasshi; 1963 Sep; 67():620-6. PubMed ID: 14054939
    [No Abstract]   [Full Text] [Related]  

  • 49. Investigations of antiviral substances present in normal horse and calf sera.
    Zilka E; Kawaklova L; Vicari G; Archetti I
    Arch Gesamte Virusforsch; 1968; 25(2):177-87. PubMed ID: 4179412
    [No Abstract]   [Full Text] [Related]  

  • 50. Different virus-precipitating activities of neutralizing monoclonal antibodies that recognize distinct sites of poliovirus particles.
    Taniguchi K; Urasawa S
    Arch Virol; 1987; 92(1-2):27-40. PubMed ID: 2432854
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neutralization anti-IgG test for antisera to Venezuelan equine encephalomyelitis.
    Hahon N
    J Gen Virol; 1970 Feb; 6(2):285-91. PubMed ID: 4191165
    [No Abstract]   [Full Text] [Related]  

  • 52. Neutralization of poliovirus by antibody-mediated polymerization.
    Brioen P; Dekegel D; Boeyé A
    Virology; 1983 Jun; 127(2):463-8. PubMed ID: 6306919
    [TBL] [Abstract][Full Text] [Related]  

  • 53. THE FORMATION AND PROPERTIES OF POLIOVIRUS-NEUTRALIZING ANTIBODY. I. 19S AND 7S ANTIBODY FORMATION: DIFFERENCES IN KINETICS AND ANTIGEN DOSE REQUIREMENT FOR INDUCTION.
    SVEHAG SE; MANDEL B
    J Exp Med; 1964 Jan; 119(1):1-19. PubMed ID: 14113113
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Poliovirus neutralization and the percentage law. Brief report.
    Brioen P; Boeyé A
    Arch Virol; 1985; 83(1-2):105-11. PubMed ID: 2982345
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Neutralization of poliovirus by a monoclonal antibody: kinetics and stoichiometry.
    Icenogle J; Shiwen H; Duke G; Gilbert S; Rueckert R; Anderegg J
    Virology; 1983 Jun; 127(2):412-25. PubMed ID: 6306918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [SUSCEPTIBILITY OF STRAIN T9 TO POLIOMYELITIS VIRUS I, II AND III STUDIED WITH FLUORESCENT AMINOCRIDINES AND ANTIBODIES].
    BARQUET JS; ALVAREZ B; EPSTEIN B
    Medicina (B Aires); 1964; 24():98-101. PubMed ID: 14151304
    [No Abstract]   [Full Text] [Related]  

  • 57. [DETECTION OF ANTIBODIES TO MONKEY VIRUS (OB40) IN HUMAN SERA. SEROLOGICAL EVIDENCE OF INFECTION FROM MONKEYS AND KIDNEY CULTURES].
    CHUMAKOVA MIa; CHUMAKOV MP; ELBERT LB; AVGUSTINOVICH GI; RALF NM; VOROSHILOVA MK; TARANOVA GP; TAPUPERE VO
    Vopr Virusol; 1963; 29():457-60. PubMed ID: 14071285
    [No Abstract]   [Full Text] [Related]  

  • 58. Difference in mechanism of viral neutralization under in vitro and in vivo conditions.
    Cremer NE; Lennette EH; Hagens SJ; Fujimoto FY
    J Immunol; 1966 Feb; 96(2):284-8. PubMed ID: 4160485
    [No Abstract]   [Full Text] [Related]  

  • 59. Use of monoclonal antibodies prepared with Sabin vaccine viruses for the characterization of poliovirus strains isolated in Canada.
    Wachmann B; Henning D; Armstrong R; Boucher DW; Contreras G; Furesz J
    Dev Biol Stand; 1984; 57():141-9. PubMed ID: 6084605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunological aspects of pemphigus and its treatment with antipolio vaccande (Sabin) in steroids.
    Földvári F; Fornosi F; Angyal J; Bottyán E
    Acta Derm Venereol; 1968; 48(6):630-2. PubMed ID: 4185304
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.